Development of a single item patient reported measure of treatment side effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

By afschroeder • June 28, 2026

Berthelsen DB, Horgan B, Simon L, Ioannidis JPA, Goel N, Tugwell P, Balay-Dustrude E, Bartlett SJ, Bingham CO, Boers M, Bouillot C, Böhm P, Choy E, Cowern M, Dagsvik K, Djurtoft C, Furst DE, Haugegaard T, Hazlewood GS, Hoens AM, Jørgensen TS, Kelly SE, Kruzikas D, Musaus J, Richards P, Shea BJ, Strand V, Thomas M, Torralba K, Voshaar M, Weinbrecht-Mischkewitz M, Woodworth TG, Wright G, Flurey C, Christensen R; OMERACT Safety Working Group. Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement. Semin Arthritis Rheum. 2026 Jun 19;79:153026. doi: 10.1016/j.semarthrit.2026.153026. Epub ahead of print. PMID: 42364594.

Tags: Adverse events, Core outcome set, Harms, Large language model, OMERACT, Publications, Rheumatology, rheumatology, safety

Biological sex differences in the United States CTEPH Registry

Cirulis MM, Auger WR, Benza RL, Channick RN, Chin K, Davis RD, Elliott CG, He F, Jain S, LaCroix AZ, Madani MM, McLaughlin V, Tapson[...]

Social and clinical determinants of liver transplant evaluation in hepatocellular carcinoma: A multicenter cohort study

Tincopa M, Bridi L, Vodkin I, Yilma M, Zhou K, Kwong A, Singh J, Mehta N, Kuo A, Hirose R, Wisel SA, Steggerda JA, Freise[...]

Gender Minority Stress and Resilience Factors Associated With Persistent Depressive Symptoms Among Transgender and Gender Diverse Adolescents and Young Adults Accessing Gender-Affirming Medical Care

Conn BM, Durazo-Arvizu R, Wong CF, West AE, Chen D, Chan YM, Ehrensaft D, Garofalo R, Hidalgo MA, Rosenthal SM, Olson-Kennedy J. Gender Minority Stress[...]